SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-059750
Filing Date
2023-11-07
Accepted
2023-11-07 07:00:35
Documents
64
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q sage-20230930.htm   iXBRL 10-Q 3423461
2 EX-10.1 sage-ex10_1.htm EX-10.1 113569
3 EX-10.2 sage-ex10_2.htm EX-10.2 91728
4 EX-31.1 sage-ex31_1.htm EX-31.1 12079
5 EX-31.2 sage-ex31_2.htm EX-31.2 12058
6 EX-32.1 sage-ex32_1.htm EX-32.1 10738
7 GRAPHIC img93204646_0.jpg GRAPHIC 106549
  Complete submission text file 0000950170-23-059750.txt   12164032

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sage-20230930_cal.xml EX-101.CAL 43272
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sage-20230930_lab.xml EX-101.LAB 439553
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sage-20230930_pre.xml EX-101.PRE 334595
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sage-20230930_def.xml EX-101.DEF 221334
12 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sage-20230930.xsd EX-101.SCH 53186
58 EXTRACTED XBRL INSTANCE DOCUMENT sage-20230930_htm.xml XML 2529345
Mailing Address 215 FIRST STREET CAMBRIDGE MA 02142
Business Address 215 FIRST STREET CAMBRIDGE MA 02142 617-299-8380
Sage Therapeutics, Inc. (Filer) CIK: 0001597553 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36544 | Film No.: 231381490
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences